The Canadian Optimal Therapy of COPD Trial: Design, Organization and Patient Recruitment

BACKGROUND: There are no published studies that have assessed whether adding long-acting beta 2-agonist bronchodilators and/or inhaled steroids to chronic therapy with tiotropium would provide additional clinical benefit to patients with moderate to severe chronic obstructive pulmonary disease (COPD...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Shawn D Aaron, Katherine Vandemheen, Dean Fergusson, Mark FitzGerald, Francois Maltais, Jean Bourbeau, Roger Goldstein, Andrew McIvor, Meyer Balter, Denis O'Donnell
Format:	Artigo
Jezik:	Inglês
Izdano:	Wiley 2004-01-01
Serija:	Canadian Respiratory Journal
Online dostop:	http://dx.doi.org/10.1155/2004/394710
Oznake:	Označite Brez oznak, prvi označite!